Our findings reveal LHX1 as a master transcriptional repressor of STING-mediated senescence and highlight the therapeutic potential of targeting the LHX1-LDB1 axis to restore tumor-suppressive SASP in HNSCC. This evidence concerns the gene LHX1 and neoplasm.